`571.272.7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper 18
`
` Date: April 22, 2021
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG, NOVARTIS TECHNOLOGY LLC, and
`NOVARTIS PHARMACEUTICALS CORP.,
`Patent Owner.
`____________
`
`IPR2020-01317
`Patent 9,220,631 B2
`____________
`
`
`
`
`
`Before Eric W. Hawthorne, Supervisory Trial Paralegal
`
`
`
`
`
`NOTIFICATION OF WITHDRAWAL OF RECEIPT OF POP REQUEST
`
`The Office received a request for Precedential Opinion Panel (POP) review
`of an issue raised in this case from Petitioner Regeneron Pharmaceuticals, Inc. See
`Ex. 3003. On April 16, 2021, the Office received a request from Petitioner to
`withdraw the request because the parties have settled this matter. See Ex. 3004.
`Accordingly, the POP review request is withdrawn.
`
`
`
`IPR2020-01317
`Patent 9,220,631 B2
`
`
`For PETITIONER:
`Elizabeth Weiswasser
`Anish Desai
`Brian Ferguson
`Christopher Pepe
`elizabeth.weiswasser@weil.com
`anish.desai@weil.com
`brian.ferguson@weil.com
`christopher.pepe@weil.com
`
`For PATENT OWNER:
`
`Elizabeth Holland
`William James
`Linnea Cipriano
`Joshua Weinger
`eholland@goodwinprocter.com
`wjames@goodwinlaw.com
`lcipriano@goodwinlaw.com
`jweinger@goodwinprocter.com
`
`
`
`2
`
`